Literature DB >> 7235042

Optimized blood sampling protocols and sequential design of kinetic experiments.

J J DiStefano.   

Abstract

Design of optimal blood sampling protocols for kinetic experiments is discussed and evaluated, with the aid of several examples--including an endocrine system case study. The criterion of optimality is maximum accuracy of kinetic model parameter estimates. A simple example illustrates why a sequential experiment approach is required; optimal designs depend on the true model parameter values, knowledge of which is usually a primary objective of the experiment, as well as the structure of the model and the measurement error (e.g., assay) variance. The methodology is evaluated from the results of a series of experiments designed to quantify the dynamics of distribution and metabolism of three iodothyronines, T3, T4, and reverse-T3. This analysis indicates that 1) the sequential optimal experiment approach can be effective and efficient in the laboratory, 2) it works in the presence of reasonably controlled biological variation, producing sufficiently robust sampling protocols, and 3) optimal designs can be highly efficient designs in practice, requiring for maximum accuracy a number of blood samples equal to the number of independently adjustable model parameters, no more or less.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7235042     DOI: 10.1152/ajpregu.1981.240.5.R259

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  Linear spectral deconvolution of catabolic plasma concentration decay in dialysis.

Authors:  D Liberati; F Turkheimer
Journal:  Med Biol Eng Comput       Date:  1999-05       Impact factor: 2.602

2.  Experimental design and efficient parameter estimation in population pharmacokinetics.

Authors:  M K al-Banna; A W Kelman; B Whiting
Journal:  J Pharmacokinet Biopharm       Date:  1990-08

3.  Pharmacokinetic and pharmacodynamic data collection in children and neonates. A quiet frontier.

Authors:  J T Gilman; P Gal
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

4.  Determination of the distribution volume that can be used to calculate the intravenous loading dose.

Authors:  D R Wada; D R Drover; H J Lemmens
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

5.  Voxelwise quantification of [(11)C](R)-rolipram PET data: a comparison between model-based and data-driven methods.

Authors:  Gaia Rizzo; Mattia Veronese; Paolo Zanotti-Fregonara; Alessandra Bertoldo
Journal:  J Cereb Blood Flow Metab       Date:  2013-03-20       Impact factor: 6.200

6.  Experimental design and efficient parameter estimation in preclinical pharmacokinetic studies.

Authors:  E I Ette; C A Howie; A W Kelman; B Whiting
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

Review 7.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

8.  A spectral analysis approach for determination of regional rates of cerebral protein synthesis with the L-[1-(11)C]leucine PET method.

Authors:  Mattia Veronese; Alessandra Bertoldo; Shrinivas Bishu; Aaron Unterman; Giampaolo Tomasi; Carolyn Beebe Smith; Kathleen C Schmidt
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-03       Impact factor: 6.200

Review 9.  Paediatric labelling requirements. Implications for pharmacokinetic studies.

Authors:  J T Wilson; G L Kearns; D Murphy; S J Yaffe
Journal:  Clin Pharmacokinet       Date:  1994-04       Impact factor: 6.447

10.  New compartmental model approach to dialysis.

Authors:  D Liberati; S Biasioli; R Foroni; F Rudello; F Turkheimer
Journal:  Med Biol Eng Comput       Date:  1993-03       Impact factor: 2.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.